In the latest session, The Clorox Company (NYSE: CLX) closed at $160.25 down -1.58% from its previous closing price of $162.82. In other words, the price has decreased by -$2.57 from its previous closing price. On the day, 1131164 shares were traded. CLX stock price reached its highest trading level at $162.80 during the session, while it also had its lowest trading level at $160.12.
Ratios:
For a deeper understanding of The Clorox Company’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 81.74 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 76.08. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 871.33 whereas as Long-Term Debt/Eq ratio is at 825.33.
Upgrades & Downgrades
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 02 when MACKAY A D DAVID sold 1,000 shares for $140.63 per share. The transaction valued at 140,630 led to the insider holds 600 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 20.72B and an Enterprise Value of 23.63B. As of this moment, The’s Price-to-Earnings (P/E) ratio for their current fiscal year is 269.78, and their Forward P/E ratio for the next fiscal year is 28.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 19.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.76 while its Price-to-Book (P/B) ratio in mrq is 8012.50. Its current Enterprise Value per Revenue stands at 3.30 whereas that against EBITDA is 50.61.
Stock Price History:
Over the past 52 weeks, CLX has reached a high of $178.21, while it has fallen to a 52-week low of $120.50. The 50-Day Moving Average of the stock is 161.71, while the 200-Day Moving Average is calculated to be 148.78.
Shares Statistics:
For the past three months, CLX has traded an average of 1.19M shares per day and 982.51k over the past ten days. A total of 123.65M shares are outstanding, with a floating share count of 122.88M. Insiders hold about 0.10% of the company’s shares, while institutions hold 82.20% stake in the company. Shares short for CLX as of Apr 27, 2023 were 5.18M with a Short Ratio of 5.18M, compared to 5.44M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.19% and a Short% of Float of 4.75%.
Dividends & Splits
According to the company, the forward annual dividend rate for CLX is 4.72, from 4.72 in the trailing year. Against a Trailing Annual Dividend Yield of 2.90%, it implies a Forward Annual Dividend Yield of 2.90%. The stock’s 5-year Average Dividend Yield is 2.63. The current Payout Ratio is 778.60% for CLX, which recently paid a dividend on May 11, 2023 with an ex-dividend date of Apr 24, 2023. Stock splits for the company last occurred on Aug 23, 1999 when the company split stock in a 2:1 ratio.
Earnings Estimates
There are 15 different market analysts currently analyzing its stock. On average, analysts expect EPS of $1.14 for the current quarter, with a high estimate of $1.38 and a low estimate of $0.96, while EPS last year was $0.93. The consensus estimate for the next quarter is $1.39, with high estimates of $1.67 and low estimates of $1.16.
Analysts are recommending an EPS of between $4.81 and $4.38 for the fiscal current year, implying an average EPS of $4.55. EPS for the following year is $5.69, with 17 analysts recommending between $6.2 and $5.29.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $1.87B this quarter.It ranges from a high estimate of $1.91B to a low estimate of $1.81B. As of the current estimate, The Clorox Company’s year-ago sales were $1.8B, an estimated increase of 4.00% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $1.82B, an increase of 7.30% over than the figure of $4.00% in the same quarter last year. There is a high estimate of $1.85B for the next quarter, whereas the lowest estimate is $1.78B.
A total of 17 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $7.28B, while the lowest revenue estimate was $7.18B, resulting in an average revenue estimate of $7.24B. In the same quarter a year ago, actual revenue was $7.11B, up 1.80% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $7.45B in the next fiscal year. The high estimate is $7.6B and the low estimate is $7.31B. The average revenue growth estimate for next year is up 2.90% from the average revenue estimate for this year.